Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure (Q34510023)

2 August 2017

title

Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure (English)

1 reference

2 August 2017

Stewart WC

1 reference

2 August 2017

Sharpe ED

1 reference

2 August 2017

Harbin TS Jr

1 reference

2 August 2017

Pastor SA

1 reference

2 August 2017

Day DG

1 reference

2 August 2017

Holmes KT

1 reference

2 August 2017

Stewart JA

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

American Journal of Ophthalmology

2 August 2017

published in

1 reference

2 August 2017

volume

129

1 reference

2 August 2017

1 reference

2 August 2017

page(s)

723-727

1 reference

A double-masked crossover study comparing the effects of carteolol 1% and 2% on intra-ocular pressure.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900381-0

Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900381-0

MK-507 versus sezolamide. Comparative efficacy of two topically active carbonic anhydrase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900381-0

Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900381-0

A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900381-0

The cardiovascular, pulmonary, and ocular hypotensive effects of 0.2% brimonidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900381-0

A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Dorzolamide-Timolol Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900381-0

Alpha-adrenergic receptors and blood pressure control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900381-0

Development and use of brimonidine in treating acute and chronic elevations of intraocular pressure: a review of safety, efficacy, dose response, and dosing studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900381-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9394(00)00381-0

1 reference

2 August 2017

1 reference